Drug-related problems among pediatric patients with cancer admitted to the pediatric haemato-oncology department: A prospective observational study
- 4 April 2026
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
Abstract
Background: Pediatric patients undergoing chemotherapy often need to take multiple medications. Consequently, they may experience drug-related problems (DRPs), including adverse drug reactions, drug interactions, and various medication errors. Methods: A prospective observational study was conducted over three months in the Pediatric Haemato-oncology department of a cancer specialty hospital of Nepal following ethical approval. DRPs were identified from patient medical records and the literature and, recorded according to the Pharmaceutical Care Network Europe V9.1 tool. Data were collected and analyzed using IBM SPSS Statistics V20 and Microsoft Excel 2013 to present the findings. Results: Among the 30 enrolled patients, 211 DRPs were identified in 28 patients (93.3%), averaging 7.5 DRPs per patient, all validated through case-by-case review. Treatment safety was the predominant DRP type (n = 131; 62.09%), followed by treatment ineffectiveness (n = 79; 37.44%). Drug selection (n = 116; 51.76%) and dispensing issues (n = 51; 22.77%) were the leading causes, with anti-infective drugs (n = 41; 35%) and antineoplastic agents (n = 24; 20.5%) most frequently implicated. Conclusion: DRPs were prevalent among pediatric patients with cancer, with treatment safety being the most significant issue and drug selection being the primary cause. Anti-infective drugs were most frequently involved in DRPs, followed by antineoplastic and immunomodulating agents.Keywords
This publication has 33 references indexed in Scilit:
- Comprehensive assessment of pain characteristics, quality of life, and pain management in cancer patients: a multi-center cross-sectional studyQuality of Life Research, 2024
- Psychotropic Medication Use and Polypharmacy Among Children and Adolescents Initiating Intensive Behavioral Therapy for Severe Challenging BehaviorThe Journal of Pediatrics, 2024
- Traditional, complementary, and alternative medicine in cancer care: Challenges and opportunitiesAsia-Pacific Journal of Oncology Nursing, 2023
- Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancerCancer, 2023
- Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatmentJournal of Cancer Research and Clinical Oncology, 2021
- Evaluation of pharmacists’ interventions on drug-related problems and drug costs in patients with cancer painInternational Journal of Clinical Pharmacy, 2021
- Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in ChinaInternational Journal of Clinical Pharmacy, 2019
- Polypharmacy in elderly cancer patients: Challenges and the way clinical pharmacists can contribute in resource‐limited settingsAging Medicine, 2019
- Drug-drug interactions in pediatric oncology patientsPediatric Blood & Cancer, 2017
- Censuses: Current Approaches and Methods2015